Regular ArticleOccult Lymph Node Metastases Detected by Cytokeratin Immunohistochemistry Predict Recurrence in Node-Negative Endometrial Cancer
References (21)
- et al.
Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma
Gynecol Oncol
(1998) - et al.
Surgery without radiotherapy for primary treatment of endometrial cancer
Obstet Gynecol
(1998) - et al.
Relationship between surgical–pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study
Gynecol Oncol
(1991) - et al.
Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy
Gynecol Oncol
(1997) - et al.
The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
Cell
(1982) - et al.
Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
Lancet
(1992) - et al.
Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence
Surgery
(1996) - et al.
Surgical pathologic spread patterns of endometrial cancer
Cancer
(1987) - et al.
Risk factors and recurrent patterns in Stage I endometrial cancer
Am J Obstet Gynecol
(1985) - et al.
Lymphadenectomy in high risk endometrial carcinoma stage I and II: No more morbidity and no need for external pelvic radiation
Int J Gynecol Cancer
(1999)
Cited by (118)
Retroperitoneal para-aortic ectopic pregnancies: A review of reported cases
2023, Gynecology and Obstetrics Clinical MedicineOncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study
2021, Gynecologic OncologyCitation Excerpt :For example, 4 of the 14 f ITC patients with NE had recurrence by 4 years despite receiving ATx. Although these pathologic criteria are well established as risk factors among patients with node-negative and node-positive EC [17,18], their utility and role in risk-stratifying disease progression among LVM patients is just beginning to be elicited [19,20]. Similar to our study, Aloisi et al. [21] retrospectively examined risk factors for recurrence among 79 LVM patients with a 97.2% ATx rate.
Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?
2021, Gynecologic OncologyCitation Excerpt :Although several studies to date have examined the significance of ITCs, all are limited by small numbers of patients with ITCs and most patients received adjuvant therapy. Two studies (cohorts of patients between 1986 and 1995 [17] and 1997–2004 [18]) retrospectively performed ultrastaging on all lymph nodes of patients with stage I or II disease. These studies reported that occult (IHC positive) lymph node metastases were associated with LVSI [17,18] and deep myometrial invasion [18].
- 1
To whom correspondence should be addressed. Fax: +81-561-62-2991. E-mail: [email protected].